The current article is a review of the most important, accessible and relevant literature published between April 2020 and March 2021 on the gut microbiota and inflammatory bowel disease (IBD) treatments. The major areas of publication during this period were human studies involving probiotic supplementation and fecal microbiota transplantation including mechanistic insights from animal models as well as papers covering the more traditional pharmacological IBD treatments.
To cite this article
Gut microbiota and inflammatory bowel disease treatment
Microb Health Dis 2021;
Submission date: 02 Jun 2021
Revised on: 21 Jun 2021
Accepted on: 30 Jun 2021
Published online: 09 Sep 2021
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.